Outset Medical (Nasdaq: OM) today announced two senior secured credit facilities with investment affiliates managed by SLR Capital Partners. Collectively, the facilities provide for up to $300 million in borrowing for the maker of the Tablo Hemodialysis System. The facilities include an up-to-$250-million term loan facility and an up-to-$50-million asset-based revolving credit facility. Outset drew $100 […]
Dialysis
FDA clears heat purification, remote therapy from Fresenius
Fresenius Medical Care North America (FMCNA) recently announced FDA clearances for two of its technologies used in dialysis care. Today, the Waltham, Massachusetts-based company announced FDA clearance for the AquaA water system. The company designed it as a water purification system for hemodialysis. Yesterday, the FDA granted 510(k) clearance to upgrade Fresenius’ Liberty Select cycler. […]
Outset Medical unveils TabloCart for Tablo hemodialysis system
Outset Medical (Nasdaq:OM) this week launched the newest accessory for its Tablo Hemodialysis System, the TabloCart. The San Jose, California-based company designed TabloCart to help medical professionals easily move anywhere around the hospital. It provides added maneuverability and optional prefiltration or storage. [Hear more from Outset Medical CEO Leslie Trigg at DeviceTalks West on October 20] […]
Baxter is reportedly considering a sale of its kidney care businesses
Baxter (NYSE:BAX) is reportedly weighing the divestiture of its renal care services and hemodialysis business. According to a Bloomberg report, the company is considering splitting with its kidney care businesses as part of a refocusing effort after its $12.5 billion acquisition of Hillrom last year. The outlet cited anonymous sources familiar with the matter. The […]
Baxter, The Links partner to raise kidney health awareness in Black communities
Baxter (NYSE:BAX) announced today that it expanded its partnership with The Links to improve awareness and resources related to kidney health. An international not-for-profit organization, The Links will join Baxter to bring awareness to the disproportionate challenges affecting Black Americans related to kidney health. Deerfield, Illinois-based Baxter is committing an incremental $800,000 in funding to […]
Fresenius’ NxStage launches Speedswap for critical care dialysis
Fresenius Medical Care North America’s renal therapies group announced today that it launched the Speedswap for the NxStage System One with NxView. Speedswap, a new option for the NxStage System One with NxView, enables the changing of a flow-compromised dialysis filter without replacing the entire cartridge. According to a news release, Fresenius designed the new […]
Fresenius Medical Care spins its Health Partners business into three-way merger
Fresenius Medical Care announced today that the three-way merger it announced earlier this year has closed. In March, Fresenius entered into an agreement to create a new company for providing kidney care. The agreement involves Fresenius Health Partners (Fresenius Medical Care North America’s value-based care division) entering into a combination with InterWell Health and Cricket […]
Outset Medical wins national VA contract
Outset Medical (Nasdaq:OM) announced today that it has won a national contract with the U.S. Department of Veterans Affairs to sell its Tablo hemodialysis system into the department’s 106 VA hospitals. San Jose, California–based Outset already has Tablo deployed at some VA hospitals, which overall provide dialysis for 35,000 U.S. veterans. But the new five-year […]
Law firm notifies investors of class action suit against Outset Medical
Levi & Korsinksy notified Outset Medical (Nasdaq:OM) investors today of a class action securities lawsuit against the company. In June, Outset announced that it was holding shipments of its Tablo hemodialysis system for home use as a result of a pending FDA review and clearance of a 510(k) submitted for changes made since the Tablo system’s […]
Fresenius Medical Care reports labor issues, inflation challenges as it cuts 2022 outlook
Fresenius Medical Care (NYSE:FMS) shares are up slightly on second-quarter results that topped the consensus forecast. The Bad Homburg v. d. Höhe, Germany-based dialysis company posted profits of $150.3 million (€147 million), or 51¢ (€0.50) per share, on sales of $4.9 (€4.75 billion) billion for the three months ended June 30, 2022, for a 32.9% […]
Outset Medical stock skyrockets on resumed Tablo shipments
Outset Medical (Nasdaq:OM) shares are up big today on the news that people needing dialysis will once again be able to receive Tablo systems for home use. The news of the shipment hold’s end was enough to counteract Q2 earnings misses, sending OM shares up 21.5% at $18.77 per share in midday trading. MassDevice‘s MedTech […]